Acute GvHD: Are You Avoiding These Common Treatment Pitfalls?
Allogenic hematopoietic stem cell transplantation (allo-HSCT) can be curative for many patients with hematologic malignancies. However, graft-versus-host disease (GvHD) remains one of the most common complications and one of the leading causes of death after unrelated HSCT. GvHD triples mortality rates.
Presentation Year: 2023